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Several reports have shown that cutaneous leishmaniasis lesions are painless, suggesting that Leishmania
infection interferes with pain perception. Comparisons of inﬂammation-induced hyperalgesia between
BALB/c and C57BL/6 mice have been little explored in the literature, and comparative data regarding
nociception in leishmaniasis are non-existent. In susceptible BALB/c mice and resistant C57BL/6 mice that
were intradermally inoculated with a low dose of Leishmania major in the ear, we investigated the vari-
ation in nociception over a 12-wk period post-infection and this variation’s association with the structure
of nerve ﬁbres and the presence of endogenous cytokines that are classically considered hyper- or hypo-
nociceptive. Infected BALB/c mice presented susceptibility and severe lesions. Infected C57BL/6 mice
exhibited resistance and healing lesions. The immune response involved pro- and anti-inﬂammatory
cytokine secretion, respectively. The infection-induced hypoalgesia in BALB/c mice after wks 9 was
accompanied by decreased levels of IL-6 and IL-10 in ear tissue with intact nerves. C57BL/6 mice showed
short-lived hyperalgesia in wks 2, which was related to increased local levels of IL-6, KC/CXCL-1, TNF-a
and IL-10 and a decrease in nerve density. The increase in pro-inﬂammatory cytokine IL-6, KC/CXCL-1 and
TNF-a levels during hyperalgesia suggested a role for these mediators in afferent nerve sensitisation,
which was secondary to the inﬂammatory damage of nerve ﬁbres stained by PGP 9.5.
In contrast, the mechanisms of hypoalgesia may include the downregulation of cytokines, the
preservation of the structure of nerve endings, and as yet uninvestigated unidentiﬁed differences ine Patologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627,
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194 S.D. Cangussú et al. / Experimental Parasitology 133 (2013) 193–200neurotransmitter release or a direct role of the parasites in the context of the progressive and permissive
inﬂammatory response of BALB/c mice.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Leishmaniasis lesions in humans generally progress into pain-
less ulcerations (Sotiropoulos and Wilbur, 2001; Morris-Jones
and Weber, 2004a, 2004b; Daboul, 2008); however, hyperalgesia
has also been reported in humans (Kubba et al., 1987) and BALB/
c mice (Kanaan et al., 2000). Endogenous cytokine production has
been associated with hyperalgesia in patients with inﬂammatory
diseases (Seitz et al., 1994) and animal models (Kanaan et al.,
2000; Cunha et al., 2005).
The immunopathology of cutaneous leishmaniasis (CL) has
been studied, but few authors have addressed the correlation be-
tween neural involvement, cytokine proﬁle and nociception. Cur-
rent paradigms of the subset of T helpers present in the lesions
of infected mice lead to the progressive increase in lesion size in
BALB/c mice, while C57BL/6 mice present lesion resolution in both
the classical model (high doses, footpad, subcutaneous) (Heinzel
et al., 1989) and low-dose model (ear, intradermic) (Belkaid
et al., 1998; Cangussú et al., 2009).
The intraplantar injection of cytokines that are generally re-
garded as pro-inﬂammatory (IL-1b, IL-6, IL-8 and TNF-a) has been
implicated in hyperalgesia, and anti-inﬂammatory cytokines (IL-4,
IL-10 and TGF-b) have been described to have hyponociceptive ef-
fects (Cunha et al., 1999, 2000; Vale et al., 2003). However, there is
a lack of information about the proﬁle of endogenous cytokines in
analgesia and hypoalgesia.
The nociceptive phenomenon in human CL induced by Leish-
mania major has been associated with inﬂammatory peripheral
neural involvement (Kubba et al., 1987; Satti et al., 1989). More-
over, among the studies dealing with CL only, hyperalgesia has
been investigated using classical models and BALB/c mice (Ahmed
et al., 1998; Kanaan et al., 2000; Karam et al., 2006; Amaral et al.,
2008).
The role of cytokines in the hyperalgesia detected in the clas-
sical BALB/c model of L. major is controversial. Some studies re-
ported increased levels of IL-6 and IL-1b in the infected footpad
(Kanaan et al., 2000; Karam et al., 2006), while others found that
IL-6 and, more importantly, IL-1b did not play a direct role in L.
major-induced hyperalgesia (Karam et al., 2011). Moreover, TNF
was not increased in this model (Kanaan et al., 2000; Karam
et al., 2006), although it has been shown to produce hyperalgesia
through a cascade of events (Ferreira et al., 1993; Cunha et al.,
2005).
Because the endogenous cytokine proﬁle has largely been stud-
ied in experimental CL lesions, we used the ear model of L. major
infection to investigate the susceptible and resistance responses
in nociception. To clarify the role of peripheral innervation and
the relevance of the cytokine proﬁle in the ear model of infec-
tion-induced disturbed nociception, we conducted this long-term
study. Throughout 12 weeks (wks) of L. major infection in BALB/c
mice, we observed permissive intracellular growth of the patho-
gen, which was associated with non-healing lesions. In contrast,
C57BL/6 mice presented severe tissue damage and clearance of
the parasite in healing lesions (Cangussú et al., 2009). The relation-
ships between changes in nociceptive thresholds, the endogenous
production of IL-1b, IL-6, KC/CXCL-1 (chemokine (C-X-C motif) li-
gand 1), IL-10 and TNF-a cytokines, and the structural changes of
nerve ﬁbres were investigated.2. Methods
2.1. Mice
Female BALB/ and C57BL/6 mice that were 8–9 wks old were
obtained from CEBIO, Instituto de Ciências Biológicas, UFMG (Belo
Horizonte, MG, Brazil). Animals were handled in accordance with
international guidelines for the use and handling of experimental
animals, and the protocol was approved by the Animal Care Com-
mittee of the Universidade Federal de Minas Gerais (CETEA/UFMG
protocol 128/05). Pain tests were carried out with strict adherence
to the ethical guidelines for the study of experimental pain in con-
scious animals (Zimmermann, 1983).
2.2. Parasite and intradermal infection
C57BL/6 and BALB/c mice were inoculated intradermally
in the right ear using a 26-gauge needle in a volume of 10 ll
PBS, as described previously (Belkaid et al., 1998). We inoculated
1  103 metacyclic L. major clone V1 promastigotes (WHO/MHOM/
80/Friedlin), which were isolated from stationary cultures
(5–6 days old) using a gradient of Ficoll PM 400 (Amersham
Biosciences – Uppsala, Switzerland) (Spath and Beverley, 2001).
The left ear dermis received an inoculation of 10 ll PBS only and
was used as a control. Contralateral sham-injected ears and
uninfected animal ears did not present statistically signiﬁcant
differences in the local cytokine proﬁle or nociceptive proﬁle.
2.3. Behavioural tests
A thermoalgesimeter test (thermal test) was used as a variation
of the hot plate (HP) and tail ﬂick (TF) tests used in other studies
(Kanaan et al., 2000; Karam et al., 2006) and was adapted by our
group to detect heat-evoked nociception-related behaviour in
mouse ears. A device (Fig. 1) was built to assess the variations of
heat-evoked nociceptive thresholds in mouse ears by the adapta-
tion of a ﬁve-phase transmission pyrography machine (Palante,
Model CM-10, São Paulo, Brazil). The factory conditions of the
apparatus were adapted with a solid metal point that reached a
maximum temperature of 45 degrees Celsius (C), which was con-
trolled by an thermostat (electrical resistance 0.41X, voltage alter-
nating current 0.88 and electric current 2.1 Å) when operating in
phase one. The apparatus had overload protection and double insu-
lation to ensure safety.
To conﬁrm the development of the thermal response, the ani-
mals were subjected to pain tests in both ears once per wk starting
1 wk before and for 12 wks after the intradermal inoculation of
1  103 metacyclic L. major promastigotes into the right ear der-
mis. The thermoalgesimetric evaluations were performed as
adapted from Savernini et al. (2012). The experiments were always
conducted between 12:00 and 17:00. The heat test was performed
on the dorsal side of both ears with a single stimulus each time,
starting with the infected ear. The stimuli on each ear in the same
animal were separated by an interval of at least 30 min. Between
measuring the response in the right and left ears, the device was
placed in the test area without thermal stimulation to conﬁrm
the speciﬁcity of the thermal response. The test was performed
at the border of the lesion regardless of its size or aspect. All the
Fig. 1. The thermoalgesimeter built to assess heat-evoked nociceptive thresholds in mouse ears. A pyrography machine (A) was adapted with a thermostat (B) to control the
heated metal extremity (C) at a maximum temperature of 45 C. A chronometer (D) was utilised to record the time necessary for the withdrawal reaction.
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sults represent data from two different experiments.
There was no variation in the pattern of nociceptive behaviour
in the uninfected ear. Uninfected animals were subjected to pain
tests over the 12 wks post-infection period, and their nociceptive
thresholds were compared to the results obtained from the contra-
lateral ears (uninfected) of infected animals. There was no signiﬁ-
cant variation between the groups in nociceptive thresholds
(p > 0.05) or cytokine measurements (p > 0.05; data not shown).
In the control group (left ear dermis), only vehicle (PBS) was in-
jected. In a quiet room that was used exclusively for the tests, the
mice were gently restrained, and after a few seconds (s) during
which they stopped struggling, the ear of each animal was placed
on the heated metal extremity with the temperature maintained
at 45 C. The time until a withdrawal reaction was measured as
the latency of the test and manually recorded with a stop watch.
The end point was characterised by the removal of the ear or the
head from the heated metal by the animal. Measurements were
made for each ear in each of the 18 animals per group. The exper-
iment was repeated twice. The effects of L. major infection were as-
sessed by comparing the latency of the ipsilateral side and the
contralateral side. A maximum time of 20 s was established to pre-
vent tissue damage.
2.4. Cytokine measurements
Before infection and at 2 and 12 wks after infection, C57BL/6
and BALB/c mice were euthanised (n = 10–15 each), and the in-
fected and control ears were removed and stored at 80 C before
processing. Brieﬂy, ear samples were homogenised in 100 ll of the
appropriate buffer (PBS containing 0.4 M NaCl, 0.05% Tween 20,
0.5% bovine serum albumin (BSA), 0.1 mM phenyl-methyl-
sulphonyl ﬂuoride, 0.1 mM benzethonium chloride, 10 mM EDTA
and 0.001% aprotinin) according to Saﬁeh-Garabedian et al.
(1995) and Cunha et al. (2008). After homogenisation, the samples
were centrifuged (3000 rpm/10 min). The cytokine/chemokine
levels were measured in the supernatant. IL-6, KC/CXCL-1, IL-10,TNF-a and IL-1b levels were determined by an enzyme-linked
immunosorbent assay (ELISA) according to the manufacturer’s
instructions. The results were expressed as picograms of each cyto-
kine per millilitre (pg/ml), and the control concentrations of these
cytokines were determined in ears injected with PBS.
2.5. Immunohistochemical expression of PGP 9.5 in ears of BALB/c and
C57BL/6 mice
The mice were euthanised at 2 and 12 wks post infection (p.i.).
Infected and control ears were removed and ﬁxed in picric acid/
formaldehyde as previously described (Stefanini et al., 1967). After
ﬁxation, the ears were sectioned longitudinally through the
inoculum site (previously demarcated) or, when noticeable,
through the induration area. The two halves were dehydrated,
cleared, embedded in parafﬁn and cut into sections 4–5 lm thick.
For immunohistochemistry, endogenous peroxidase activity was
abolished with 3.5% H2O2 for 30 min, followed by incubation with
1:40 normal goat serum (NGS) for 30 min at room temperature.
The labelled streptavidin–biotin (LSAB) method was applied in at
least 3 consecutive sections of each ear (infected and contralat-
eral). Consecutive parafﬁn sections that were 4–5 lm thick from
ears sampled at 2 and 12 wks p.i. were stained using a primary
rabbit polyclonal antibody against the neural marker protein gene
product 9.5 (PGP 9.5) (1:250; Ultraclone, UK) for 2 h at room
temperature. The secondary biotinylated antibodies used were
goat anti-rabbit antibodies, followed by streptavidin-peroxidase
complexes (DAKO-LSABR 2 system; DAKO, Carpinteria, CA). The
reaction was visualised by incubating the section with
3,3-diaminobenzidine tetrahydrochloride (Sigma, St. Louis, MO)
and counterstaining with haematoxylin. Negative controls were
prepared by incubating sections with preadsorbed antiserum and
by replacing the primary antiserum with immunoglobulins of the
same class and concentration. The images were captured and
segmented to produce binary images with a computer-assisted
image analysis system (Kontron Elektronic/Carl Zeiss, Germany).
Automated morphometrical quantiﬁcation of the PGP 9.5-positive
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ﬁelds).
2.6. Data analysis
The results were expressed as the average and standard devia-
tion (SD) of two independent experiments. The degree of signiﬁ-
cance was calculated by a one-way ANOVA followed by Tukey’s
post hoc test if the data were normally distributed or Kruskall Wal-
lis and Mann–Whitney (Wilcoxon) tests for non-parametric data.
Probability values (p) of 0.05 or less were considered signiﬁcant.
3. Results
3.1. Nociceptive thresholds
The ears of the infected animals injected with PBS (control ears)
showed stable latency when they were subjected to the thermal
test (Fig. 2). These results were similar to the levels of latency of
the thermal test in the non-injected ears of uninfected animals
(data not shown). Differences in nociception were observed follow-
ing the i.d. inoculation of 1  103 L. major metacyclic promastig-
otes in both strains of mice (Fig. 2).
In BALB/c mice, the i.d. injection of L. major produced hypoalge-
sia, with a signiﬁcant increase in the thermal latency at wks 9
(p < 0,001), 10 (p < 0.001), 11 (p = 0.04) and 12 (p = 0.03) p.i. com-
pared with the control ear (Fig. 2 A).Fig. 2. Time course of the effects of the intradermal injection of L. major on the
thermal nociception of BALB/c (A) and C57BL/6 (B) mice, as assessed by the
thermoalgesimeter test. The latencies observed in infected ears (N) were compared
to the latencies in control ears (j). Data are presented as the means ± standard
error for each group (n = 18, two repeated experiments per mouse strain). (⁄)
Signiﬁcant difference between infected and controls ears (p < 0.05).In C57BL/6 mice, differences in nociception were only observed
at wks 2 p.i (p < 0.001), when the latency of the thermal test de-
creased signiﬁcantly (hyperalgesia) compared with the control
ear (Fig. 2B).
3.2. Morphological analysis of nerve ﬁbres in ears of BALB/c and
C57BL/6 mice
In our study, nervous ﬁllets stained by PGP 9.5 were visible in
both lineages in contralateral (control) and infected ears
(Fig. 3A–D). In uninfected contralateral ears, the PGP 9.5 density
did not vary among strains of mice, but the density decreased in
C57BL/6 infected ears simultaneously with the hyperalgesia de-
tected in wks 2 (Fig. 3E).
However, in BALB/c mice, nerves were often intact despite the
degree of surrounding tissue inﬂammation at both wks 2 and 12
p.i. (Fig. 3A and C). In contrast, in C57BL/6 mice, there were signs
of axonal degeneration associated with inﬂammatory cells visible
inside the limits of the perineurum, especially at wks 2 (Fig. 3B
and D). Our morphological analysis indicated a variation in the
density of peripheral nerve ﬁbres using the PGP marker, and the
staining was clearly less intense in C57BL/6 mice at wks 2 com-
pared to the other groups, indicating structural damage. The mor-
phometric quantiﬁcation of PGP 9.5-positive ﬁbre density is shown
in Fig. 3E.
3.3. Variations in cytokine levels
The levels of IL-6, KC/CXCL-1, IL-10, TNF-a and IL-1b were mea-
sured in the infected and controls ears of BALB/c and C57BL/6 mice
(n = 10–15 each). Mice were euthanised at wks 2 and 12 following
the i.d. injection of L. major (Fig. 4).
In BALB/c mice, the levels of IL-6 and IL-10 did not change at
wks 2 p.i but decreased signiﬁcantly at wk 12 (p < 0.001 for all).
In these mice, the baseline TNF-a and KC/CXCL-1 levels did not
change between 2 and 12 wks p.i. (Fig. 4 A).
In C57BL/6 mice, the levels of IL-6, IL-10, TNF-a and KC/CXCL-1
increased signiﬁcantly (p = 0.007, p < 0.001, p < 0.001 and p < 0.001,
respectively) at wks 2 p.i and decreased at wks 12 p.i. (p = 0.007,
p < 0.001, p < 0.001 and p < 0.001, respectively) (Fig. 4B). These lev-
els returned to the control levels at wks 12 p.i. (p = 0.174). Fig. 4 A
shows the discrete variation in the level of IL-1b in both lineages.
The levels of IL-1b in the BALB/c mice decreased from an average
of 175 ± 5 pg/ml in the control ears to 111 ± 9 pg/ml in wks 2 p.i
and increased to 223 ± 6 pg/ml by the end of the 12 wks post-
injection period. In C57BL/6 mice, IL-1b levels did not differ from
the baseline level at 2 wks p.i. (Fig. 4B). These levels were
141 ± 11 pg/ml in the control and 147 ± 11 pg/ml in the infected
ears at wks 2 p.i. and increased to 201 ± 6 pg/ml at wks 12 p.i.4. Discussion
We investigated the nociceptive effect of low doses of L. major
promastigotes that were inoculated intradermally in the ears of
BALB/c (susceptible) and C57BL/6 (resistant) mice and its relation-
ship with nerve injury and the level of pro- and anti-inﬂammatory
cytokines that are considered hyper- or hypo-nociceptive (Verri
et al., 2006). In BALB/c mice, L. major produced prolonged hypoal-
gesia from wks 9. In C57BL/6 mice, the latency of the thermal test
decreased signiﬁcantly (hyperalgesia) compared with the control
ear only at wks 2 p.i.
Our results reveal two important aspects of cutaneous leish-
maniasis: ﬁrst, the nociceptive response and the cytokine proﬁle
vary for each mouse lineage; second, in agreement with the
hypothesis that nociceptive phenomena are directly associated
Fig. 3. PGP 9.5 expression in contralateral and infected ears of BALB/c and C57BL/6 mice inoculated with 103 L. majormetacyclic promastigotes. Stained nerves in the dermis
of contralateral ears of BALB/c and C57BL/6 mice (upper insets, A and B, respectively). In lesions in BALB/c mice at 2 wks (A, arrows), the nerves were often intact, but C57BL/6
mice showed unstained nerves (B, arrows and lower inset) with signs of axonal degeneration and visible inﬂammatory cells (arrows) inside the limits of the perineurum
(neuritis). At 12 wks (C, D), despite the severe inﬂammation in the surrounding tissue in BALB/c mice (C, arrowheads), the nerves remained intact in both lineages (arrows).
(E) PGP 9.5 nerve density decreased similar to hyperalgesia in C57BL/6 mice at 2 wks p.i. BALB/c mice did not present quantitative or qualitative nerve damage. ⁄Represents a
statistically signiﬁcant difference in C57BL/6 mice between control ears and infected ears 2 wks p.i. (p = 0.01) and ⁄⁄represents statistically signiﬁcant differences in C57BL/6
mice between infected ears 12 wks p.i. and 2 wks p.i (p = 0.03). Anti-PGP 9.5. Bar = 10 lm; inset bar = 20 lm.
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and morphometrical differences in nerve ﬁbre lesions and density
between the mouse lineages at wks 2 p.i but not at wks 12.
Neural involvement in cutaneous leishmaniasis induced by L.
major has been considered in mouse and human lesions, in which
inﬂammatory inﬁltrate is observed around (perineuritis) and with-
in cutaneous nerves (neuritis) in addition to the presence of the
parasite in the perineural space, as conﬁrmed by our previous mor-
phological results (Cangussú et al., 2009) and results from other
researchers (Kubba et al., 1987; Satti et al., 1989; Kanaan et al.,
2000). Through the systematic histological examination of ear tis-
sues, we excluded the massive destruction of nerves, even in the
presence of severe architectural changes detected in ear lesions.
We detected a slight but signiﬁcant decrease in ﬁbre density that
was correlated with inﬂammatory changes in resistant mice at
the peak of hyperalgesia. The presence of oedema related to theacute inﬂammatory phenomena, which are more intense during
the initial phase of the disease, may explain why both strains
showed a decrease in relative PGP staining compared to the other
time points. The quantiﬁcation of intradermal nerve ﬁbres is not an
easy task, especially in small animals. There are few references
concerning the evaluation of nerve ﬁbre density in rodents, and
in leishmaniasis, they are restricted to a few authors (Kanaan
et al. 2000). We did not observe intra-epidermal ﬁbres in mouse
ears, and we believe that only a few small nerve ﬁbres associated
with the dermal vessels and glands were properly quantiﬁed by
our method despite the limitations we faced, such as the small
thickness. To compensate for this limitation of the model, we ana-
lysed at least 3 consecutive sections of each ear (infected and con-
tralateral). We systematically measured the stained area, which
included both the easily visible and the smaller nerve proﬁles, by
automatic morphometry. The results are presented as the PGP
Fig. 4. The effect of L. major infection on the levels of cytokines measured by ELISA
in BALB/c (A) and C57BL/6 (B) mice at wks 2 and 12 following ear dermis
inoculation with 1  103 L. major metacyclic promastigotes. Levels of cytokines in
the control ears (open bars), at 2 wks (solid bars) and 12 wks p.i. (grey bars). The
bars represent the mean of 10–15 animals ± SD. (⁄) And (⁄⁄) represent statistically
signiﬁcant differences compared with the other values for each cytokine (p < 0.05).
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neuritis at wks 2–4.5, especially in C57BL/6 mice, in which the tis-
sue damage and debris were more pronounced (Cangussú et al.,
2009). At this time, we also detected hyperalgesia in C57BL/6 mice.
We did not observe a signiﬁcant difference in nerve density at any
time point for BALB/c mice. The more intense inﬂammatory re-
sponse and tissue damage in C57BL/6 mice at initial times and
their rapid resolution may be responsible for the acute hyperalge-
sia and nerve sensitisation and damage (loss of staining) in this
group compared to the different lesion pattern observed in BALB/
c mice.
In the intradermal low-dose ear model, our results provide a
clear demonstration of an early period of hyperalgesia that lasts
for approximately 15 days in C57BL/6 mice, after which sensitivity
to the thermal test returns to normal levels. In contrast, infected
BALB/c mice showed a sustained increase in the thermal latency
(hypoalgesia) after wks 9, which remained until 12 wks p.i. At that
time, we did not detect axonal damage with PGP 9.5 staining.
Previous studies have demonstrated the presence of a sustained
hyperalgesic state in BALB/c mice inoculated with a high dose of L.
major (3  105 and 2.5  106 promastigotes/hind footpad, respec-
tively), as shown by a decrease in their pain thresholds (Kanaan
et al., 2000; Karam et al., 2006), and short-lived (10 days) hyperal-
gesia in BALB/c mice inoculated with 4  103 promastigotes per
hind paw (Karam et al., 2006). These studies differ from ours by
the higher injected dose and the location of the injection (footpads
instead of ears), conditions that alter the inﬂammatory response
and could potentially alter the nociceptive response.
We cannot associate the macroscopic evolution or size of the le-
sion with the algesic patterns. In both animals, the lesions werediscrete and not ulcerated at 2 wks p.i., although only C57BL/6
mice presented thermal sensitivity compared to the uninfected
ear. Moreover, BALB/c lesions presented progressive ulceration
beginning at 5 wks, but hypoalgesia began at wks 9, and these ani-
mals never presented hyperalgesia, despite intense and persistent
ulceration until euthanasia. Between 5 and 7 wks, only a few
C57BL/6 mice presented discrete areas of superﬁcial ulceration,
which were healed by 12 wks. However, these animals exhibited
a thermal response between wks 4 and wks 12, which was similar
to the controls.
We believe that the differences in nociception that were
detected between the strains might be related to variations in
the degree of nerve damage in C57BL/6 mice, which was directly
inﬂicted by inﬂammatory cells or mediated by cytokines after
infection-induced tissue injury. This damage was paradoxically
less severe in the large BALB/c mouse lesions. The nociceptive
phenomena studied here are also associated with variations in
the tissue levels of several cytokines considered hyper- or
hypo-nociceptive, as previously described by Cunha et al. (1991,
1992, 1999), Inoue et al. (1999), and Poole et al. (1995). The
capacity to evoke hyperalgesia can be mediated by a prostaglan-
din-dependent mechanism and/or a prostaglandin-independent
mechanism. KC/CXCL-1 results in hyperalgesia involving the
sympathetic nervous system. Because KC/CXCL-1 is released by
activated macrophages and endothelial cells, it may be a humoral
link between tissue injury and sympathetic hyperalgesia (Cunha
et al. 1991). IL-6 activates the IL-1/prostaglandin hyperalgesic
pathway, whereas TNFa activates both pathways (Cunha et al.,
1992). According to Inoue et al. (1999), interleukin-1b induces
substance P release from primary afferent neurons through the
cyclooxygenase-2 system, and this phenomenon may contribute
to inﬂammation-induced hyperalgesia in the intact primary
afferent neuro-spinal cord pathway. Poole et al. (1995) suggested
that IL-10 limits the inﬂammatory hyperalgesia evoked by carra-
geenan and bradykinin through two mechanisms: the inhibition
of cytokine production and the inhibition of IL-lb-evoked PGE2
production. These authors suggest that the latter effect is not
mediated via IL-10-induced IL-Ira and may result from the
suppression of prostaglandin H synthase-2 (COX-2) by IL-10.
In C57BL/6 mice, it is noticeable that the control latency level
measured at wks 12 was approximately half of the level measured
at the beginning of the experiment (and was also approximately
half of the levels found in control BALB/c mice). It would therefore
be interesting to study the subjacent mechanism involved in the
host-parasite response. Previous studies also detected differences
in the pain behaviour between mouse strains (Larsson et al.,
2006), including a higher visceromotor response (VMR) to colorec-
tal distension before and after dextran sodium sulphate treatment
in C57BL/6 mice compared to BALB/c mice, and suggested that
there are strain- and/or model-related differences in visceral pain
responses to inﬂammation.
The levels of the cytokine IL-6 were signiﬁcantly upregulated
during hyperalgesia in C57BL/6 mice and downregulated during
hypoalgesia in BALB/c mice. These results are in line with previ-
ous reports that indicated that IL-6 plays a role in nociception in
the rat model of mechanical hyperalgesia (Cunha et al., 1992;
Sommer and Kress, 2004). Other studies have also indicated an
increase in IL-6 levels in L. major-injected footpads of BALB/c
mice, which is associated with a decrease in the latency (Kanaan
et al., 2000; Karam et al., 2006). There is evidence indicating that
IL-6 exerts its role in the development and maintenance of pain
through resident cell activation, polymorphonuclear cell inﬁltra-
tion, cytokine production, prostanoid and sympathomimetic
amine release and the activation of intracellular pathways, espe-
cially mitogen-activated protein kinase (MAPK) (Manjavachi
et al., 2010).
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cantly upregulated during hyperalgesia in C57BL/6 mice. As men-
tioned previously, TNF-a and KC/CXCL-1 produce hyperalgesia by
both exogenous administration (Cunha et al., 1991, 1992; Sommer
and Kress, 2004; Cunha et al., 2005) and endogenous production
(Cunha et al., 2003, 2005) in several models other than leishmani-
asis. However, in BALB/c mice, the levels of TNF-a and KC/CXCL-1
did not vary signiﬁcantly throughout the period of observation, in
agreement with the results of Kanaan et al. (2000), who did not de-
tect changes in the levels of TNF-a in the ‘classical model’ of infec-
tion by L. major using the same mouse strain. The KC/CXCL-1
nociceptive proﬁle has not been studied before in experimental
leishmaniasis.
IL-1b has pro-inﬂammatory activity and induces hyperalgesia
after subcutaneous injection into the rat paw (Ferreira et al.,
1988; Cunha et al., 1992) and after intraperitoneal administration
in mice (Watkins et al., 1994). Our results showed a discrete in-
crease in the levels of IL-1b in both strains after 12 wks of infection,
but this increase was accompanied by hypoalgesia only in BALB/c
mice. The IL-1b levels in C57BL/6 mice were also upregulated at
12 wks compared to the controls, despite having a nociception pro-
ﬁle similar to the baseline of the control ear, in which the IL-1 b
levels were not increased. These variations are discrete and may
not have biological relevance. Therefore, in our model, no direct
relationship between the levels of IL-1 b and variations in nocicep-
tion was observed. Our results are in agreement with those of
Karam et al. (2011), who did not detect a direct role for IL-1b in
L. major-induced hyperalgesia in the classical model of infection
in BALB/c mice.
IL-10 is a potent anti-inﬂammatory cytokine (Poole et al., 1995;
Vale et al., 2003; Karam et al., 2007; Amaral et al., 2008), and its
administration (exogenous IL-10) limits the inﬂammatory hyperal-
gesia evoked by carrageenan and bradykinin in rats (Saﬁeh-Garab-
edian et al., 1995) and mice (Vale et al., 2003; Karam et al., 2007)
through two mechanisms: the inhibition of cytokine production
and the inhibition of IL-1b-evoked PGE2 production by suppressing
prostaglandin H synthase-2 (COX-2). However, none of these
mechanisms were unequivocally demonstrated to operate in asso-
ciation with the endogenous cytokine proﬁle in leishmaniasis and
should be further investigated.
Unexpectedly, in the present study, the levels of the cytokine IL-
10 were signiﬁcantly upregulated during hyperalgesia in C57BL/6
mice and downregulated during hypoalgesia in BALB/c mice. How-
ever, in support of our observation, recent studies have indicated
increased levels of IL-10 in the seminal plasma of patients with
chronic pelvic pain syndrome, which was strictly correlated with
patient pain severity (Miller et al., 2002). Moreover, Tu et al.
(2003) found that IL-10/ mice and IL-10+/+ mice treated with
an antibody against IL-10 had an increased latency time for the
paw licking response compared to untreated IL-10+/+ mice. In their
studies, the authors proposed that endogenous IL-10 may be in-
volved in the induction of hyperalgesia. The increase in IL-10 in
C57BL/6 mice at 2 wks is likely a secondary response due to the
presence of pro-inﬂammatory cytokines and may not play a direct
role in hyperalgesia. These aspects should be further investigated
by blocking candidate cytokines, including IL-13.
There are qualitative similarities and differences between mice
and rats in terms of the cytokines released by inﬂammatory stimuli
and the hypernociceptive mechanisms of action of cytokines. TNF-
a, IL-1b, IL-6, and KC/CXCL-1 are released in rats and mice chal-
lenged with nociceptive stimuli (Karam et al., 2006, 2007; Cunha
et al., 2005). The different results reported in the literature on
the proﬁle of cytokines in mouse inﬂammatory nociception reﬂect
the complexity of the mechanisms involved in the variations of the
pain threshold. Moreover, differences in methodology can explain
the variations in proposed mechanisms. For example, there are dif-ferences in the stimulus applied before measuring the threshold
pain (thermal, mechanical), the location of stimulation (ear, foot-
pad, tail), the different strains of rats and mice used and the vehicle
administered (inﬂammatory stimulus and/or hypernociceptive
mediator).
The data on cytokine levels discussed here should be interpreted
as one element in the complex scenario of inﬂammatory nocicep-
tive phenomena, and the speciﬁcity of the evolution of L. major-
induced lesions in resistant and susceptible strains of mice should
be considered. For example, a direct association of IL-6, which
was decreased with hypoalgesia in BALB/c mice (12 wks) and
increased with hyperalgesia in C57BL/6 mice (2 wks), should be
interpreted in the context of basal differences in cytokine levels
between the mouse strains. The production of IL-6 at 2 and
12 wks in BALB/c mice and C57BL/6 mice were similar (p = 0.056
and p = 0.06; respectively); however, a signiﬁcant decrease in IL-6
levels compared to uninfected levels at 12 wks (p < 0.001) and
2 wks p.i (p < 0.001) was only detected in BALB/C mice. In contrast,
C57BL/6 mice presented increased levels compared to control mice
(p = 0.007) at wks 2 and returned to the basal level at 12 wks p.i. It is
interesting to observe that basal levels of IL-6 in BALB/c mice are
twice the values in C57BL/6 mice (p = 0.033), adding value to the
variation necessary to provoke changes in the algesic limiar more
than to the absolutes values measured. Our ﬁndings on the
association between IL-6 and hypoalgesia in BALB/c mice are in
accordance with the reduction in pro-inﬂammatory cytokines,
primarily IL-6, which has been associated with hypoalgesia by
other authors (Cunha et al., 1992).
Our results also highlight the importance of considering the
impact of inﬂammatory changes in L. major lesions that lead to
nerve damage, which in turn modulate nerve susceptibility to pain
mediators as an additional complicating factor in the nociceptive
panorama. Changes include local blood ﬂow and vascular perme-
ability changes, the activation and migration of immune cells and
changes in the release of growth and trophic factors from sur-
rounding tissues. The data on the cytokine proﬁle discussed here
should be interpreted as one element in the complex scenario of
inﬂammatory nociceptive phenomena, and the speciﬁcity of the
evolution of L. major-induced lesions in resistant and susceptible
strains of mice should be considered.
In summary, we presented a model to study inﬂammatory
nociception in mice that reinforces a role for inﬂammatory
cytokines and nerve damage in afferent nerve sensitisation and
increases our knowledge of the histopathologic component in
models of hyper- or hypoalgesia. Further investigations are ongoing
and will address aspects of pain perception in human cutaneous
leishmaniasis.
5. Conclusion
Our work uses a multidisciplinary approach that not only as-
sesses the complexity of pain in the context of a long-term infec-
tious condition that is extremely important to the public health
ﬁeld, but also indicates that speciﬁc mechanisms related to the
parasite-induced immune response should be further explored to
understand the correlation between inﬂammatory and anti-
inﬂammatory cytokines, nerve sensitisation and tissue damage.
Our data may also explain why the advanced destructive lesions
observed in some clinical forms of this disease are favoured by
the higher limiar of pain perception in patients who only receive
a clinical diagnosis and treatment late in the course of this disease.
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